Showing results (271-280 of 507) with videos related to
Sort By:
Pageof 51
IARC Scientific Publications|February 28, 2001
Susceptibility markers in colorectal cancerJ Burn, P D Chapman, D T Bishop, et al.Journal of Epidemiology and Community Health|June 1, 1995
Limb reduction defects in the northern region of England 1985-92M J Wright, J N Newell, M E Charlton, et al.Human Molecular Genetics|August 1, 1994
Angelman syndrome associated with a maternal 15q11-13 deletion of less than 200 kbJ L Buxton, C T Chan, H Gilbert, et al.Carcinogenesis|May 20, 1999
Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 monthsS L Williamson, A Kartheuser, J Coaker, et al.Parkinsonism & Related Disorders|February 14, 2014
Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's diseaseChristopher Kobylecki, David J Burn, Lewis Kass-Iliyya, et al.Brain : a Journal of Neurology|March 19, 2005
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodiesUrs P Mosimann, René M Müri, David J Burn, et al.Neurology|August 1, 1992
Adult-onset motor neuron disease and infantile Werdnig-Hoffmann disease (spinal muscular atrophy type 1) in the same familyP J Shaw, P G Ince, J Goodship, et al.Parkinsonism & Related Disorders|May 20, 2008
Impaired attention predicts falling in Parkinson's diseaseL M Allcock, E N Rowan, I N Steen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 6, 2006
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodiesS A Molloy, E N Rowan, J T O'Brien, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2008
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotypeJ-P Taylor, E N Rowan, D Lett, et al.Pageof 51